Our Chief Learning Officer, Simon Brown, talks about our ongoing efforts to build new capabilities by investing in our own people.

Learn about the role of precision oncology in advanced melanoma treatment.

Early clinical trial reports results in this hidden disease

Lisa, a patient living with CML, shares her experience and discusses the importance of speaking up about unmet needs in your disease.

Novartis researchers have discovered a compound that is showing promise against three parasites that cause three neglected diseases.

A Novartis experimental drug in clinical trial aims to block liver cancer growth

Jordan, a melanoma survivor, shares her experience with melanoma, BRAF mutation testing and the importance of patient empowerment.

In Cameroon, seeking treatment for chronic diseases can be a long journey.